About
Tirzepatide is a dual incretin receptor agonist that activates both GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) pathways. By targeting these complementary metabolic pathways, Tirzepatide helps regulate appetite, improve insulin sensitivity, and support better glucose metabolism, contributing to significant improvements in weight management and metabolic control.

Key Benefits

• Supports appetite regulation and reduced caloric intake
• Enhances insulin sensitivity and glucose metabolism
• Supports weight reduction and improved body composition
• Helps regulate blood glucose levels
• Supports overall metabolic health and cardiometabolic risk reduction

Administration
Subcutaneous injection.

Typical Clinical Use
Commonly used in weight management programs, metabolic health optimization, insulin resistance treatment, and obesity management protocols.